142 related articles for article (PubMed ID: 29201440)
1. Evaluation of ghrelin levels and endothelial functions in patients with coronary slow flow phenomenon.
Çelik O; Demirci E; Aydın M; Karabag T; Kalçık M
Interv Med Appl Sci; 2017 Sep; 9(3):154-159. PubMed ID: 29201440
[TBL] [Abstract][Full Text] [Related]
2. The effects of endothelial dysfunction and inflammation on slow coronary flow.
Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
[TBL] [Abstract][Full Text] [Related]
3. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow.
Tanriverdi H; Evrengul H; Enli Y; Kuru O; Seleci D; Tanriverdi S; Tuzun N; Kaftan HA; Karabulut N
Cardiology; 2007; 107(4):313-20. PubMed ID: 17264512
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow.
Wang Y; Jia PY; Chen BJ; Chen Y; Yu H; Yu Y; Yang HM; Jia DL; Ma CY
Cardiology; 2017; 138(3):141-146. PubMed ID: 28651248
[TBL] [Abstract][Full Text] [Related]
5. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.
Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M
Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414
[TBL] [Abstract][Full Text] [Related]
6. Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow.
Gazi E; Temiz A; Altun B; Barutcu A; Silan F; Colkesen Y; Ozdemir O
Cardiovasc J Afr; 2014; 25(1):9-14. PubMed ID: 24435163
[TBL] [Abstract][Full Text] [Related]
7. Correlation between endothelial dysfunction and occurrence of no-reflow in patients undergoing post-thrombolysis early invasive percutaneous intervention for ST-elevation myocardial infarction.
Elbendary MAW; Saleh MA; Sabet SS; Bastawy I
Egypt Heart J; 2022 Sep; 74(1):70. PubMed ID: 36178560
[TBL] [Abstract][Full Text] [Related]
8. Vessel heterogeneity of TIMI frame count and its relation to P-wave dispersion in patients with coronary slow flow.
Zhuang X; Peng Y; Bardeesi AS; Bardisi ES; Liao X; Luo C
J Thorac Dis; 2016 Mar; 8(3):476-81. PubMed ID: 27076943
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon.
Demirci E; Çelik O; Kalçık M; Bekar L; Yetim M; Doğan T
Interv Med Appl Sci; 2019 Jun; 11(2):89-94. PubMed ID: 32148911
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
[TBL] [Abstract][Full Text] [Related]
11. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries.
Celebi H; Catakoglu AB; Kurtoglu H; Sener M; Hanavdelogullari R; Demiroglu C; Aytekin V; Aytekin S
Cardiovasc Revasc Med; 2008; 9(3):144-8. PubMed ID: 18606377
[TBL] [Abstract][Full Text] [Related]
12. The value of the TIMI frame count method in the diagnosis of coronary no-reflow: a comparison with myocardial perfusion SPECT in patients with acute myocardial infarction.
Sahin M; Basoglu T; Canbaz F; Elcik M; Kosus A
Nucl Med Commun; 2002 Dec; 23(12):1205-10. PubMed ID: 12464786
[TBL] [Abstract][Full Text] [Related]
13. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M
Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937
[TBL] [Abstract][Full Text] [Related]
14. P-wave duration and dispersion in patients with coronary slow flow and its relationship with Thrombolysis in Myocardial Infarction frame count.
Dogan SM; Yildirim N; Gursurer M; Aydin M; Kalaycioglu E; Cam F
J Electrocardiol; 2008; 41(1):55-9. PubMed ID: 16920140
[TBL] [Abstract][Full Text] [Related]
15. Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation.
Luo C; Wu X; Huang Z; Du Z; Hao Y; Hu C; Huang Y; Gao X
Int J Cardiol; 2013 Aug; 167(4):1176-80. PubMed ID: 22483250
[TBL] [Abstract][Full Text] [Related]
16. Effects of nebivolol on endothelial function and exercise parameters in patients with slow coronary flow.
Tiryakioglu S; Tiryakioglu O; Ari H; Basel MC; Bozat T
Clin Med Cardiol; 2009 Nov; 3():115-9. PubMed ID: 20508771
[TBL] [Abstract][Full Text] [Related]
17. Plasma nitric oxide level and its role in slow coronary flow phenomenon.
Sezgin N; Barutcu I; Sezgin AT; Gullu H; Turkmen M; Esen AM; Karakaya O
Int Heart J; 2005 May; 46(3):373-82. PubMed ID: 16043934
[TBL] [Abstract][Full Text] [Related]
18. Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography.
Sanati H; Zahedmehr A; Firouzi A; Salehi N; Maadani M; Shakerian F; Kiani R; Golnari P; Parchami-Ghazaee S; Peighambari M
Res Cardiovasc Med; 2013 May; 2(2):95-8. PubMed ID: 25478501
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the relationship between coronary flow rates and myocardial perfusion abnormality in patients with nonobstructive coronary artery disease: an observational study in cardiac syndrome X and coronary slow flow.
Özde C; Aktüre G; Aytekin S; Sayin AE; Ay EK; Coçkun G; Kaya A; Kayapinar O
Nucl Med Commun; 2019 Nov; 40(11):1122-1129. PubMed ID: 31568270
[TBL] [Abstract][Full Text] [Related]
20. Assessment of triglyceride/glucose index with respect to coronary slow flow.
Buber I; Nar R; Kaya D; Senol H; Adali MK; Nar G
Bratisl Lek Listy; 2022; 123(8):585-588. PubMed ID: 35852510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
